Lannett (LCI) receives FDA approval for ANDA supplement for phentermine HCI capsules, 15 mg
Tweet
Share
E-mailGet Alerts LCI Hot Sheet
Join SI Premium – FREE
Lannett (NYSE: LCI) receives FDA approval for ANDA supplement for phentermine HCI capsules, 15 mg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool
- Oppenheimer adds managing director, promotes municipal leader
- Qiagen names Jonathan Pratt as CEO, replacing Thierry Bernard
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
